Name: 글로벌 시장 동향
SKU: MD7595
Availability: InStock

보고서 요약(국문)

개요
전 세계 기능적 전기 자극(FES) 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 보이며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
기능적 전기 자극(FES)은 근육의 움직임을 돕기 위해 통증 없는 약한 전기 자극을 근육에 가하는 치료법입니다. FES는 근육을 자극하여 근육 활동을 유도하고, 근육 강화를 통해 근육 경직을 감소시킵니다.
FES는 운동 신경을 자극하여 근육 수축을 유도합니다. 근육 약화 또는 경직이 있는 경우 재활 및 기능 유지에 널리 사용됩니다. FES는 약화되거나 손상되었거나 마비된 근육에 저강도 전기 자극을 가하여 환자의 기능과 이동성을 향상시키는 데 도움을 줍니다.
시장 동향: 성장 동인 및 제약 요인
척수 손상 환자를 위한 기능적 전기 자극 시스템의 혁신
혁신 증가와 첨단 기기 출시 증가는 시장 성장을 견인할 것으로 예상됩니다.

예를 들어, 2023년 7월 Motive Health는 미국 식품의약국(FDA) 승인을 받은 Motive Knee 근육 자극 장치를 출시했습니다.
또한, 2022년 7월 헬스케어 기술 스타트업 Pulsetto는 미주신경을 자극하는 신경 조절 장치를 출시했습니다. 전기 자극으로 미주신경을 자극하면 부교감 신경계가 활성화되어 신체가 휴식을 취하고 이완될 수 있습니다.
이 외에도 만성 통증 증가, 신경근 손상 및 척수 손상 증가 또한 시장 성장을 견인할 것으로 예상됩니다.

제한 요인
엄격한 기기 승인 규제
긴 승인 절차로 인해 신제품 출시가 지연되고 있습니다. 엄격한 기기 허가 규정과 다양한 전기 자극 시스템 대안이 시장 성장을 저해할 것으로 예상됩니다.

또한, 기기의 높은 가격과 치료 절차와 관련된 위험도 시장 성장을 저해할 것으로 예상됩니다.

시장 세분화 분석
전 세계 기능적 전기 자극(FES) 시장은 제품 유형, 기기 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
척수 자극 기기 부문은 시장 점유율의 45.2%를 차지했습니다.
척수 자극은 약한 전류를 사용하여 척수의 특정 신경 섬유를 자극하는 치료법입니다. 척수 자극은 특정 부위의 통증 완화에 도움을 줍니다. 척수 손상 발생 건수 증가와 자극 기기 공급 증가가 이 부문의 성장을 견인할 것으로 예상됩니다.
예를 들어, 2021년 1월 보스턴 사이언티픽(Boston Scientific)은 웨이브라이터 알파(WaveWriter Alpha) 척수 자극기(SCS) 시스템 포트폴리오를 출시했습니다.
2022년 12월 애보트(Abbott)는 만성 통증 치료를 위한 세계에서 가장 작은 이식형 충전식 척수 자극 시스템을 출시했습니다. 이처럼 척수 손상 발생 건수 증가는 척수 자극 기기에 대한 수요 증가로 이어지고 있습니다.
지역 분석
북미는 전 세계 기능적 전기 자극 시장에서 중요한 위치를 차지할 것으로 예상됩니다.
북미는 가장 큰 시장 점유율을 기록했습니다. 만성 통증의 유병률 증가, 부상 증가, 재활 센터를 선호하는 사람들의 증가로 인해 이 지역은 시장에서 주도적인 위치를 유지할 것으로 예상됩니다. 또한, 기술 발전과 의료 기기 제조 증가는 이 지역 시장 성장을 촉진할 것으로 전망됩니다.
예를 들어, 미국 질병통제예방센터(CDC)에 따르면 2021년 미국 성인의 20.9%, 즉 5,160만 명이 만성 통증을 경험했으며, 6.9%, 즉 약 1,710만 명이 심각한 만성 통증을 경험한 것으로 추산됩니다.
CDMRP 보고서에 따르면 평생 치료가 필요한 장기적인 후유증을 동반하는 심각한 부상이 있는 것으로 추산됩니다. 약 30만 명이 척수 손상(SCI)을 안고 살아가고 있으며, 미국에서는 매년 1만 7천 건 이상의 새로운 SCI 사례가 발생하는 것으로 추산됩니다. 따라서 위의 요인들이 시장 성장을 촉진할 것으로 예상됩니다.

COVID-19 영향 분석
COVID-19는 제조 기업과 의료 부문에 전례 없는 영향을 미쳤습니다. 이는 COVID-19 기간 동안 부과된 제한 조치 때문입니다. 봉쇄 조치는 정부의 제한으로 인해 국경을 넘어 의료기기를 공급하는 데 큰 어려움을 초래했으며, 이 기간 동안 노동력 부족 또한 시장 성장에 영향을 미쳤습니다.

시장 세분화
제품 유형별
• 유선
• 무선
기기 유형별
• 척수 자극기
• 심부뇌 자극기
• 미주신경 자극기
• 천골신경 자극기
• 위 전기 자극기
• 신경근 전기 자극기
• 두개 전기 자극기
• 기타
적용 분야별
• 통증 관리
• 신경 및 운동 장애 관리
• 근골격계 질환 관리
• 요실금 관리
• 기타
최종 사용자별
• 병원
• 전문 클리닉
• 신경외과 센터
• 외래 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양 지역
• 중동 및 아프리카
경쟁 환경
상당한 시장 점유율을 차지하는 주요 기업으로는 Boston Scientific Corporation, AxioBionics Inc., Nevro Corp, Medtronic Plc, NeuroMetrix, Inc., BTL Industries, Inc., Zynex Inc., Abbott Laboratories, Hocoma AG, OMRON Healthcare 등이 있습니다.
주요 개발 사항
• 2022년 12월, 미국 식품의약국(FDA)은 Abbott의 Eterna 척수 자극(SCS) 시스템을 만성 통증 치료제로 승인했습니다.
• 2022년 1월, 생체 전자 회사인 NeuroSigma Inc.는 외부 삼차신경 자극(eTNS)을 사용하여 주의력 결핍 과잉 행동 장애(ADHD) 아동을 치료하는 생체 전자 의료 기기를 상용화했습니다.

• 2022년 9월, Evolution Devices는 신경학적 원인으로 인한 부분 보행 마비 환자의 보행 재활을 위한 EvoWalk 플랫폼 시범 프로그램을 시작했습니다.
보고서 구매 이유:

• 제품 유형, 기기 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 기능적 전기 자극(FES) 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴할 수 있습니다.

• 모든 세그먼트를 포함한 기능적 전기 자극 치료 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 기능적 전기 자극 시장 보고서는 약 69개의 표, 75개의 그림, 180페이지 분량입니다.
대상 고객 (2023년 기준):
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Functional Electrical Stimulation Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Functional electrical stimulation (FES) is a treatment that involves painless, mild electrical stimulation to a muscle or muscles to help them move. Functional Electrical Stimulation helps initiate muscle activity by stimulating the muscles to strengthen muscle activity to reduce muscle spasticity.
FES stimulates the motor nerves to achieve muscle contraction. It is used widely in rehabilitation and maintenance of function where there is muscle weakness or tightness. FES applies low-level electrical impulses to weakened, damaged, or paralyzed muscles to help improve people’s capability and mobility.
Market Dynamics: Drivers & Restraints
Innovations in functional electrical stimulation systems for spinal cord injuries
The increase in innovations and increase in the launch of advanced devices is expected to drive market growth.
For instance, in July 2023, Motive Health introduced the US Food and Drug Administration (FDA)-approved Motive Knee muscle stimulation device.
For instance, in July 2022, Healthtech startup Pulsetto launched a neuromodulation device that stimulates the vagus nerve. Stimulating the vagus nerve with electric impulses activates the parasympathetic nervous system by allowing the body to rest and relax.
Additionally, an increase in chronic pain and the increase in neuromuscular injuries and spinal cord injuries is also expected to drive market growth.
Restraint
Stringent regulations for device approvals
Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.
Additionally, the high cost of the devices and the risks associated with the treatment procedures are expected to hinder market growth.
Segment Analysis
The global functional electrical stimulation market is segmented based on product type, device type, application, end-user and region.
Spinal cord stimulation devices segment accounted for 45.2% of the market share
Spinal cord stimulation uses a mild electrical current to stimulate certain nerve fibers in the spinal cord. Spinal cord stimulation helps in targeted pain relief. The increase in the number of spinal cord injuries and increase in the number of stimulation devices is expected to drive the segment growth.
For instance, in January 2021, Boston Scientific introduced the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems.
In December 2022, Abbott launched the world's smallest implantable, rechargeable spinal cord stimulation system for chronic pain. Thus, the increase in the number of spinal cord injuries increases the demand for spinal cord stimulation devices.
Geographical Analysis
North America is expected to hold a significant position in the global functional electrical stimulation market share
North America accounted for the largest market share. The increasing prevalence of chronic pain and increasing injuries and increase in the number of individuals preferring rehabilitation centers is expected to hold the region in the dominant position. Additionally, increasing technological advancements and increasing manufacturing of medical devices are also expected to raise the market growth in the region.
For instance, according to the Centers for Disease Control and Prevention, it is estimated that in 2021, 20.9% of U.S. adults i.e., 51.6 million individuals experienced chronic pain, and 6.9% i.e., approximately 17.1 million individuals experienced high-impact chronic pain.
According to the CDMRP report, it is estimated that there are serious injuries with long-term consequences requiring lifelong care. It is estimated that about 300,000 individuals are living with an SCI, and over 17,000 new cases occur in the U.S. each year. Thus, the above factors are expected to raise the market growth.
COVID-19 Impact Analysis
COVID-19 has had an unprecedented impact on manufacturing companies and the health sector, this is due to the restrictions imposed during the COVID-19 period. Lockdown has created a major challenge in supplying the devices across borders due to the restrictions imposed by the governments and the lack of labor during the period has also affected the market growth.
Market Segmentation
By Product Type
• Wired
• Wireless
By Device Type
• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Vagus Nerve Stimulation Devices
• Sacral Nerve Stimulation Devices
• Gastric Electric Stimulation Devices
• Neuromuscular Electrical Stimulation Devices
• Cranial Electrical Stimulation Devices
• Others
By Application
• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Incontinence Management
• Others
By End-User
• Hospitals
• Specialty Clinics
• Neurosurgical Centers
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The leading companies with a significant market share include Boston Scientific Corporation, AxioBionics Inc., Nevro Corp, Medtronic Plc, NeuroMetrix, Inc., BTL Industries, Inc., Zynex Inc., Abbott Laboratories, Hocoma AG, OMRON Healthcare among others
Key Developments
• In December 2022, the U.S. Food and Drug Administration (FDA) approved Abbott's Eterna spinal cord stimulation (SCS) system for the treatment of chronic pain
• In January 2022, Bioelectronics company NeuroSigma Inc. commercially launched a bioelectronic medical device that uses external trigeminal nerve stimulation (eTNS) to treat children with attention deficit/hyperactivity disorder (ADHD).
• In September 202, Evolution Devices launched its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis.
Why Purchase the Report?
• To visualize the global functional electrical stimulation market segmentation based on product type, device type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of functional electrical stimulation treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global functional electrical stimulation market report would provide approximately 69 tables, 75 figures, and 180 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Device Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovations in functional electrical stimulation systems for spinal cord injuries
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Stringent regulations for device approvals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Wired *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Wireless
8. By Device Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
8.1.2. Market Attractiveness Index, By Route of Administration
8.2. Spinal Cord Stimulation Devices*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Deep Brain Stimulation Devices
8.4. Vagus Nerve Stimulation Devices
8.5. Sacral Nerve Stimulation Devices
8.6. Gastric Electric Stimulation Devices
8.7. Neuromuscular Electrical Stimulation Devices
8.8. Cranial Electrical Stimulation Devices
8.9. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Pain Management*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurological and Movement Disorder Management
9.4. Musculoskeletal Disorder Management
9.5. Incontinence Management
9.6. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Neurosurgical Centers
10.5. Ambulatory Surgical Centers
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Boston Scientific Corporation*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. AxioBionics Inc.
13.3. Nevro Corp
13.4. Medtronic Plc
13.5. NeuroMetrix, Inc.
13.6. BTL Industries, Inc.
13.7. Zynex Inc.
13.8. Abbott Laboratories
13.9. Hocoma AG
13.10. OMRON Healthcare
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Boston Scientific Corporation, 4.	Key Developments, AxioBionics Inc., Nevro Corp, Medtronic Plc, NeuroMetrix, Inc., BTL Industries, Inc., Zynex Inc., Abbott Laboratories, Hocoma AG, OMRON Healthcare

표 목록 (Tables)

List of Tables

Table 1 Global Functional Electrical Stimulation Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Functional Electrical Stimulation Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Functional Electrical Stimulation Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Functional Electrical Stimulation Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Functional Electrical Stimulation Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Functional Electrical Stimulation Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Functional Electrical Stimulation Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 10 Global Functional Electrical Stimulation Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Functional Electrical Stimulation Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Functional Electrical Stimulation Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Functional Electrical Stimulation Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 18 North America Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Functional Electrical Stimulation Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 23 South America Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Functional Electrical Stimulation Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 28 Europe Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Functional Electrical Stimulation Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Functional Electrical Stimulation Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Functional Electrical Stimulation Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Functional Electrical Stimulation Market Value, By Device Type, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Functional Electrical Stimulation Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Functional Electrical Stimulation Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Boston Scientific Corporation: Overview

Table 41 Boston Scientific Corporation: Product Portfolio

Table 42 Boston Scientific Corporation: Key Developments

Table 43 AxioBionics Inc.: Overview

Table 44 AxioBionics Inc.: Product Portfolio

Table 45 AxioBionics Inc.: Key Developments

Table 46 Nevro Corp: Overview

Table 47 Nevro Corp: Product Portfolio

Table 48 Nevro Corp: Key Developments

Table 49 Medtronic Plc: Overview

Table 50 Medtronic Plc: Product Portfolio

Table 51 Medtronic Plc: Key Developments

Table 52 NeuroMetrix, Inc.: Overview

Table 53 NeuroMetrix, Inc.: Product Portfolio

Table 54 NeuroMetrix, Inc.: Key Developments

Table 55 BTL Industries, Inc.: Overview

Table 56 BTL Industries, Inc.: Product Portfolio

Table 57 BTL Industries, Inc.: Key Developments

Table 58 Zynex Inc.: Overview

Table 59 Zynex Inc.: Product Portfolio

Table 60 Zynex Inc.: Key Developments

Table 61 Abbott Laboratories: Overview

Table 62 Abbott Laboratories: Product Portfolio

Table 63 Abbott Laboratories: Key Developments

Table 64 Hocoma AG: Overview

Table 65 Hocoma AG: Product Portfolio

Table 66 Hocoma AG: Key Developments

Table 67 OMRON Healthcare: Overview

Table 68 OMRON Healthcare: Product Portfolio

Table 69 OMRON Healthcare: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 2 Global Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 4 Global Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Functional Electrical Stimulation Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Functional Electrical Stimulation Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Wired Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 9 Wireless Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 10 Global Functional Electrical Stimulation Market Y-o-Y Growth, By Device Type, 2022-2030 (%)

Figure 11 Spinal Cord Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 12 Deep Brain Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 13 Vagus Nerve Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 14 Sacral Nerve Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 15 Gastric Electric Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 16 Neuromuscular Electrical Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 17 Cranial Electrical Stimulation Devices Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 18 Others Device Type in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 19 Global Functional Electrical Stimulation Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 20 Pain Management Application in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 21 Neurological and Movement Disorder Management Application in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 22 Musculoskeletal Disorder Management Application in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 23 Incontinence Management Application in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 24 Others Application in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 25 Global Functional Electrical Stimulation Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 26 Hospitals End-User in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 27 Specialty Clinics End-User in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 28 Neurosurgical Centers End-User in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 29 Ambulatory Surgical Centers End-User in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 30 Others End-User in Global Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 31 Global Functional Electrical Stimulation Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 32 North America Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 33 Asia-Pacific Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 34 Europe Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 35 South America Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 36 Middle East and Africa Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 37 North America Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 38 North America Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 39 North America Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 40 North America Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 41 North America Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 42 North America Functional Electrical Stimulation Market Share, By Country, 2022 & 2030 (%)

Figure 43 South America Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 44 South America Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 45 South America Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 46 South America Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 47 South America Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 48 South America Functional Electrical Stimulation Market Share, By Country, 2022 & 2030 (%)

Figure 49 Europe Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 50 Europe Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 51 Europe Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 52 Europe Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 53 Europe Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 54 Europe Functional Electrical Stimulation Market Share, By Country, 2022 & 2030 (%)

Figure 55 Asia-Pacific Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 56 Asia-Pacific Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 57 Asia-Pacific Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 58 Asia-Pacific Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 59 Asia-Pacific Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 60 Asia-Pacific Functional Electrical Stimulation Market Share, By Country, 2022 & 2030 (%)

Figure 61 Middle East & Africa Functional Electrical Stimulation Market Value, 2021-2030 (US$ Million)

Figure 62 Middle East & Africa Functional Electrical Stimulation Market Share, By Product Type, 2022 & 2030 (%)

Figure 63 Middle East & Africa Functional Electrical Stimulation Market Share, By Device Type, 2022 & 2030 (%)

Figure 64 Middle East & Africa Functional Electrical Stimulation Market Share, By Application, 2022 & 2030 (%)

Figure 65 Middle East & Africa Functional Electrical Stimulation Market Share, By End-User, 2022 & 2030 (%)

Figure 66 Boston Scientific Corporation: Financials

Figure 67 AxioBionics Inc.: Financials

Figure 68 Nevro Corp: Financials

Figure 69 Medtronic Plc: Financials

Figure 70 NeuroMetrix, Inc.: Financials

Figure 71 BTL Industries, Inc.: Financials

Figure 72 Zynex Inc.: Financials

Figure 73 Abbott Laboratories: Financials

Figure 74 Hocoma AG: Financials

Figure 75 OMRON Healthcare: Financials

글로벌 기능적 전기 자극 시장 – 2023-2030

Global Functional Electrical Stimulation Market - 2023-2030